Gentian's CEO Dr Hilja Ibert @ BIOTALK podcast

22. Oct 2019 | 2 min read

Gentian's CEO Dr Hilja Ibert @ BIOTALK podcast

 

Podcast: CEO Dr Hilja Ibert at BioTalk

Gentian’s CEO Dr Hilja Ibert, PhD, joined BioTalk host Rich Bendis, Founder, President and CEO BioHealth Innovation Inc. at the Capital Region Investor Conference last week. In this podcast Dr Ibert talks about Gentian’s presence in the US market, biomarkers and how Gentian focuses on innovating diagnostic efficiency.

Listen to the podcast now:

 

 

HiljaandRichRecording_web-ready

 

BioHealth Innovation and Gentian

Gentian’s subsidiary in the US, Gentian USA, Inc. collaborates with BioHealth Innovation (BHI) in order to expand Gentian’s presence in the USA. BHI is an innovation intermediary that translates relevant market research into commercial success by connecting management, funding, and markets. The collaboration allows Gentian to support current and new US customers and OEM partners more closely, and will also make Gentian's products more visible to a larger US customer base.

 

You may also read


The value of calprotectin in COVID-19 highlighted at AACC 2020

Jan 14, 2021

The value of calprotectin in COVID-19 highlighted at AACC 2020

How can calprotectin support management of COVID-19 patients? As hospitals continue to navigate challenges of..

Cystatin C - recommended by KDIGO and NICE

Jan 07, 2021

Cystatin C - recommended by KDIGO and NICE

Cystatin C is superior biomarker of renal function1 and it is recommended by KDIGO2 and NICE3. Glomerular..